IRT Group

Projects

Currently Ongoing Projects

The following projects are currently under development by the IRTGroup:

FONDECYT REGULAR 1221611 (ANID-Chile)

"Unveiling naturally presented epitopes targeted by CD8+ T cells from rheumatoid arthritis patients: one step forward to understand the immunopathogenesis of the disease".
2022-2026. Principal Investigator: Dr. Juan Carlos Aguillon

FONDECYT REGULAR 1181853 (ANID-Chile)

“Identifying immunodominant T-cell antigen-peptides and T-cell responses in rheumatoid arthritis: A further step in the development of an antigen-specific dendritic cell-based therapy to restore self-tolerance”.
2018-2022. Principal Investigator: Dr. Juan Carlos Aguillón.

REDES 180028 (ANID-Chile)

"International research network on characterization of new therapeutic targets for rheumatoid artritis".
2018-2022. Principal Investigator: Dr. Juan Carlos Aguillón.

Fondef Second Stage ID15I20080 (ANID-Chile)

"Autoantigenic peptides presented by tolerogenic dendritic cells: a personalized therapy to re-train the immune system of patients with rheumatoid arthritis".
2018-2021. Director: Dr. Juan Carlos Aguillón

Fondef R&D ID18I10243 (ANID-Chile)

"Pre-clinical evaluation and registration of tolerogenic dendritic cells pulsed with autoantigenic peptides (TOLDeC-AP) for antigen-specific immunotherapy of rheumatoid arthritis".
2018-2021. Director: Dr. Juan Carlos Aguillón